The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors Maxx Pharma Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type Designation or determination (2) (-) Designation or determination (2) ARTG (16) ARTG (16) Cancellation by sponsor (6) Cancellation by sponsor (6) Australian Public Assessment Report (AusPAR) (3) Australian Public Assessment Report (AusPAR) (3) Prescription medicine decision summary (3) Prescription medicine decision summary (3) Prescription medicine registration (3) Prescription medicine registration (3) Show more Date 2024 (2) 2024 (2) Search Filters applied:Designation or determinationClear all Sponsor content2 result(s) found, displaying 1 to 2 Notice for dexrazoxane (Maxx Pharma Pty Ltd) 11 October 2024 Designation or determination Orphan drug Notice for dexrazoxane (Maxx Pharma Pty Ltd) 4 October 2024 Designation or determination Orphan drug
Notice for dexrazoxane (Maxx Pharma Pty Ltd) 11 October 2024 Designation or determination Orphan drug